ArticleRMD open2025

Persistent-relapsing SARS-CoV-2 infection following rituximab treatment for autoimmune rheumatic diseases: diagnosis and outcomes.

Katerina Chavatza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.